84-3249-77 [取扱停止]SUSD2, CT (SUSD2, Sushi Domain (SCR Repeat) Containing Protein 2, BK65A6.2, FLJ227781) (MaxLight 750) 100ul 042494-ML750

※お見積書はカートで印刷できます

冷蔵

特徴

  • MaxLight™750 is a new Near IR stable dye conjugate comparable to DyLight™750, Alexa Fluor™700 and offers better labeling efficiency, brighter imaging and increased immunodetection.
  • Absorbance (759nm); Emission (780nm); Extinction Coefficient 240,000.
  • Routinely used therapies are not adequate to treat the heterogeneity of breast cancer, and consequently, more therapeutic targets are desperately needed.
  • To identify novel targets, we generated a breast cancer cDNA library enriched for genes that encode membrane and secreted proteins.
  • From this library we identified SUSD2 (Sushi Domain Containing 2), which encodes an 822-amino acid protein containing a transmembrane domain and functional domains inherent to adhesion molecules.
  • Previous studies describe the mouse homolog, Susd2, but there are no studies on the human gene associated with breast cancer.
  • Immunohistochemical analysis of human breast tissues showed weak or no expression of SUSD2 in normal epithelial cells, with the endothelial lining of vessels staining positive for SUSD2.
  • However, staining was observed in pathologic breast lesions and in lobular and ductal carcinomas.
  • SUSD2 interacts with galectin-1 (Gal-1), a 14kD secreted protein that is synthesized by carcinoma cells and promotes tumor immune evasion, angiogenesis, and metastasis.
  • Interestingly, we found that localization of Gal-1 on the surface of cells is dependent on the presence of SUSD2.
  • Various phenotype assays indicate that SUSD2 increases the invasion of breast cancer cells and contributes to a potential immune evasion mechanism through induction of apoptosis of Jurkat T cells.
  • Using a syngeneic mouse model, we observed accelerated tumor formation and decreased survival in mice with tumors expressing Susd2.
  • We found significantly fewer CD4 tumor infiltrating lymphocytes in mice with tumors expressing Susd2.
  • Together, our findings provide evidence that SUSD2 may represent a promising therapeutic target for breast cancer.
  • Applications:Suitable for use in Western Blot, Immunohistochemistry and FLISA.
  • Other applications have not been tested.
  • Recommended Dilution:Immunohistochemistry: Formalin-fixed, paraffin-embedded sections Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Store product at 4°C in the dark.
  • DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Caution: MaxLight™750 conjugates are sensitive to light.
  • For maximum recovery of product, centrifuge the original vial prior to removing the cap.
  • Note: Applications are based on unconjugated antibody.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A and peptide affinity chromatography.
  • Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™750.
  • Specificity:Recognizes human SUSD2.
  • Isotype:IgG
  • Calc Applications Abbrev:FLISA IHC WB
  • Calc Crossreactivity:Hu
  • Immunogen:KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 716-745 in the C-terminal region of human SUSD2.
  • Shelf Life:1year
  • Swiss Prot Number:Q9UGT4
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-3249-77
型番
042494-ML750
入り数
1個
標準価格
203,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る